Silverman A., Roy CCPediatric clinical gastroenterology, 3rd ed., St. Louis, MO: C. V. Mosby, 1983.
2.
Schwarz KB, Burris GC, deMello DE, et al. Prolonged elevation of transaminase concentration in children with unsuspected myopathy. Am J Dis Child1984;138:1121-3.
3.
Rutledge J., Anderson J., Fink CW, et al. Persistent hypertransaminasemia as the presenting finding of childhood muscle disease. Clin Pediatr1985 ; 9:500-3.
4.
Pearson CM, Rimer DG, Mommaerts WFHM. A metabolic myopathy due to absence of muscle phosphorylase . Am J Med1961;30:502-17.
5.
Dubowitz V., Brooke MHMuscle biopsy: A modern approach. Philadelphia: W. B. Saunders, 1973.
6.
Howell RRThe diagnostic value of serum enzyme measurements. J Pediatr1966;68:121-34.
7.
Wroblewski F.The clinical significance of transaminase activities of serum. Am J Med1959;27:911-9.
8.
Wroblewski F. , LaDue JSSerum glutamic pyruvic transaminase in cardiac and hepatic disease. Proc Soc Exp Biol Med1956; 11:569-71.
Zimmerman HJFunction and integrity of the liver. In: Henry JB, ed. Clinical diagnosis and management by laboratory methods. Philadelphia: W. B. Saunders , 1984;217-50.
11.
Munsat TL, Baloh R., Pearson CM, Fowler W.Serum enzyme alterations in neuromuscular disorders. JAMA1973;226:1536-43.
12.
Pearson CMSerum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. N Engl J Med1957;256:1069-75.
13.
Fowler WM, Pearson CMDiagnostic and prognostic significance of serum enzymes: II Neurologic diseases other than muscular dystrophy. Arch Phys Med Rehabil1964;45:117-24.
14.
Howell RR, Williams JCThe glycogen storage diseases. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease. 5th ed. New York: McGraw Hill, 1983;141-66.
15.
Schmid R., Hammaker L.Hereditary absence of muscle phosphorylase (McArdle's syndrome). N Engl J Med1961;264:223-5.
Rowland LP, Lovelace RE, Schotland DL, et al. The clinical diagnosis of McArdle's disease. Neurology1966;16:93-100.
18.
Dietz AA, Lubrano T., Rubinstein HMLDH isoenzymes. In: Cooper GR, ed. Standard methods in clinical chemistry. New York: Academic Press, 1972;7:49-61.
19.
Bouchier Iad , Pennington CRSerum bile acids in hepatobiliary disease . Gut1978;19:492-6.
20.
Skrede S., Solberg HE, Blomhoff JP, et al. Bile acids measured in serum during fasting as a test for liver disease. Clin Chem1978;24:1095-9.
21.
Nemeth A., Samudson K., Strandvik B.Serum bile acids as markers of juvenile liver disease in alpha-1-antitrypsin deficiency. J Pediatr Gastroenterol Nutr1982 ;1:479-83.
22.
Monroe PS, Baker AL, Schneider JF, et al. Aminopyrine breath test and serum bile acids reflect histologic severity in chronic hepatitis. Hepatology1982;2:317-22.
23.
Korman MG, Hoffman AF, Summerskill Whj.Assessment of activity in chronic active liver disease: Serum bile acids compared with conventional tests and histology. N Engl J Med1974;290:1399-402.
24.
Douglas JG, Beckett GJ, Nimmo IA, et al. Clinical value of bile salts in anicteric liver. Gut1978;19:141-8.
25.
Ferraris R. , Colombatti G., Fiorentini MT, et al. Diagnostic value of serum bile acids and routine liver function tests in hepatobiliary diseases. Dig Dis Sci1983;28:129-36.
26.
Hofmann AFThe aminopyrine demethylation breath test and the serum bile acid level: Nominated but not yet elected to join the common liver tests. Hepatology1982;2:512-7.